Search Results

Article Topics

Your search for Kah Poh (Melissa) Loh, MBBCh, BAO matches 2 pages

Showing 1 - 2

rituxan

dacogen

imbruvica

venclexta

By Kah Poh (Melissa) Loh, MBBCh, BAO / August 10, 2019

Highlights in Geriatric Hematology From the ASH Annual Meeting & Exposition

GUEST EDITOR Geriatrics for the Oncologist is guest edited by Stuart M. Lichtman, MD, FACP, FASCO, and developed in collaboration with the International Society of Geriatric Oncology (SIOG). Dr. Lichtman is an Attending Physician at Memorial Sloan Kettering Cancer Center, Commack, New York, and...

By Kah Poh (Melissa) Loh, MBBCh BAO / October 10, 2017

Obtaining a Second Graduate Degree During Fellowship: Things to Consider

KAH POH (MELISSA) LOH, MBBCh BAO Institution: Fellow, University of Rochester Medical CenterMember since: 2013ASCO activities: Trainee Council Hematology and oncology fellowship training requires at least 3 years to complete. For fellows who wish to single board in either hematology or oncology, a ...

Search Results

Article Topics

Your search for Kah Poh (Melissa) Loh, MBBCh, BAO matches 2 pages

Highlights in Geriatric Hematology From the ASH Annual Meeting & Exposition

Obtaining a Second Graduate Degree During Fellowship: Things to Consider

Pembrolizumab Plus Axitinib in Previously Untreated Advanced Renal Cell Carcinoma

A Visiting Resident Oncologist’s Training During the COVID-19 Pandemic

Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Pancreatic Cancer Across Age Groups Additional Analysis of the POLO Trial

Third- or Later-Line Treatment With Infigratinib in Patients With Cholangiocarcinoma and FGR2 Fusions

Ursodeoxycholic Acid for Preventing Gallstones After Gastrectomy for Gastric Cancer

Addition of an ATR Inhibitor to Gemcitabine in Platinum-Resistant High-Grade Serous Ovarian Cancer

FDA Approves Maintenance Avelumab for the Treatment of Advanced Urothelial Carcinoma

Addition of First-Line Atezolizumab to Vemurafenib and Cobimetinib in Patients With Unresectable Advanced BRAF V600–Mutant Melanoma

Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects

Management of HER2-Positive Breast Cancer: Business as Usual?